SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.
Company profile
Ticker
SOPH
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Exelixis • Sana Biotechnology • Ginkgo Bioworks • Bio-Techne ...
SEC CIK
SOPH stock data
News
Morgan Stanley Maintains Overweight on Sophia Genetics, Lowers Price Target to $13
10 Aug 22
Sophia Genetics: Q2 Earnings Insights
9 Aug 22
Sophia Genetics Q2 EPS $(0.31) Beats $(0.39) Estimate, Sales $11.70M Miss $11.95M Estimate
9 Aug 22
Earnings Scheduled For August 9, 2022
9 Aug 22
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
28 Jun 22
Press releases
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
9 Aug 22
SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
4 Aug 22
SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
29 Jul 22
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting
15 Jun 22
SOPHiA GENETICS Publishes Environmental, Social and Governance Impact Summary
15 Jun 22
Analyst ratings and price targets
Calendar
15 Mar 22
16 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Dec 21 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Annual (USD) | Dec 21 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Institutional ownership, Q1 2022
15.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 27 |
Opened positions | 16 |
Closed positions | 7 |
Increased positions | 2 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 205.12M |
Total shares | 23.76M |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Generation Investment Management | 6.79M | $52.48M |
Balderton Capital VI, S.L.P. | 3.36M | $47.4M |
TROW T. Rowe Price | 2.32M | $17.93M |
Banque Pictet & Cie | 2.1M | $16.21M |
Partner Fund Management | 2.01M | $15.57M |
CS Credit Suisse | 1.85M | $14.33M |
Jennison Associates | 1.5M | $11.59M |
PFG Principal Financial Group Inc - Registered Shares | 877.19K | $6.78M |
Pura Vida Investments | 829.93K | $6.42M |
Pictet Asset Management | 586.3K | $4.53M |
Financial report summary
?Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Financial reports
Current reports
6-K
Index to Consolidated Financial Statements
9 Aug 22
6-K
Current report (foreign)
15 Jun 22
6-K
Current report (foreign)
15 Jun 22
6-K
SOPHiA GENETICS Achieves CE-IVD Certification using its SOPHiA DDM™ Platform
14 Jun 22
6-K
Invitation to the Annual General Meeting
16 May 22
6-K
Index to Consolidated Financial Statements
10 May 22
6-K
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors
5 May 22
6-K
Current report (foreign)
26 Apr 22
6-K
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
15 Mar 22
6-K
Current report (foreign)
14 Mar 22
Registration and prospectus
F-3
Shelf registration (foreign)
8 Aug 22
424B4
Prospectus supplement with pricing info
23 Jul 21
S-8
Registration of securities for employees
23 Jul 21
S-8
Registration of securities for employees
23 Jul 21
8-A12B
Registration of securities on exchange
19 Jul 21
F-1/A
Registration statement (foreign) (amended)
19 Jul 21
F-1
Registration statement (foreign)
2 Jul 21
DRS
Draft registration statement
23 May 21
DRSLTR
Correspondence regarding draft registration statement
23 May 21
Proxies
No filings
Other
EFFECT
Notice of effectiveness
16 Aug 22
EFFECT
Notice of effectiveness
23 Jul 21
CERT
Certification of approval for exchange listing
22 Jul 21
CORRESP
Correspondence with SEC
19 Jul 21
CORRESP
Correspondence with SEC
19 Jul 21
CORRESP
Correspondence with SEC
6 Jul 21
CORRESP
Correspondence with SEC
1 Jul 21
UPLOAD
Letter from SEC
21 Jun 21
Ownership
SC 13G/A
SOPHiA GENETICS / GENERATION INVESTMENT MANAGEMENT ownership change
15 Feb 22
SC 13G
SOPHiA GENETICS / Coucke Marc ownership change
14 Feb 22
SC 13G
SOPHiA GENETICS / Balderton Capital VI, S.L.P. ownership change
10 Feb 22
SC 13G
SOPHiA GENETICS / GENERATION INVESTMENT MANAGEMENT ownership change
6 Jan 22
Patents
Utility
Methods to compress, encrypt and retrieve genomic alignment data
19 Jul 22
A genomic data decoder may jointly compress and encrypt genomic data alignment information while preserving the privacy of sensitive genomic data elements at retrieval stage.
Utility
Methods for Detecting and Characterizing Microsatellite Instability with High Throughput Sequencing
14 Jul 22
The characterization, classification and reporting of MSI status of patient genomic samples may be provided by high throughput genomic analysis of a set of microsatellite marker loci.
Utility
Methods for Detecting Copy-number Variations In Next-generation Sequencing
28 Apr 22
Copy Number Variants (CNV) detection methods may integrate CNV detection into workflow for next generation sequencer (NGS) data processing, in parallel with SNP and INDEL variant calling.
Utility
Methods for Detecting Copy-number Variations In Next-generation Sequencing
31 Mar 22
Copy Number Variants (CNV) detection methods described herein may efficiently integrate CNV detection into the workflow for a next generation sequencer (NGS) data processing, in parallel with SNP and INDEL variant calling.
Utility
Methods for Identifying Chromosomal Spatial Instability Such As Homologous Repair Deficiency In Low Coverage Next- Generation Sequencing Data
17 Mar 22
A genomic data analyzer may be configured to detect and characterize, with a machine learning model such as a trained convolutional neural network, the presence of a genomic instability in a tumor sample.
Reddit threads
Daily Discussion Thread - August 9th, 2022
9 Aug 22
Daily Discussion Thread - May 10th, 2022
10 May 22
Daily Discussion Thread - May 9th, 2022
9 May 22
Daily Discussion Thread - March 15th, 2022
15 Mar 22
Daily Discussion Thread - March 14th, 2022
14 Mar 22
Daily Discussion Thread - February 16th, 2022
16 Feb 22
Daily Discussion Thread - February 15th, 2022
15 Feb 22
If you are daytrading for income, you should start live daytrading with a small amount of money.
10 Feb 22
Daily Discussion Thread - February 9th, 2022
9 Feb 22
Daily Discussion Thread - February 8th, 2022
8 Feb 22